Clinical trials show progress in migraine frequency, skin cancer prevention

-
2:14
Milwaukee mother mourns son, 11, fatally shot near 68th and...
-
2:08
Driver fleeing traffic stop crashes into car at 35th and Vliet,...
-
2:31
Milwaukee leaders call on parents, community after several violent...
-
2:01
Family of woman killed by MPD squad want answers: ’How could...
-
0:30
Man dies after being crushed by machine at Palermo’s Pizza...
-
7:50
Milwaukee Fire Department highlights challenges for first responders
-
0:57
The Good Neighbor Grant Fund: Milwaukee launches program to strengthen...
-
3:44
Meteorological summer wrap up
-
0:48
Medical College of Wisconsin holds 12-hour diaper drive
-
1:12
MCTS bus driver praised for quick actions helping missing girl...
-
2:18
Back to the 80s today followed by our next rain chance
-
1:49
Local therapy group aims to help kids use art for confidence,...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.